|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
2008-7-24
|
|
pubmed:abstractText |
Trastuzumab combined with cytotoxic agents presents encouraging results in metastatic breast cancer (MBC), but cardiac toxicity limits some combinations. The synergism shown with trastuzumab and the favorable tolerability profile of vinorelbine provided the rationale for investigating this combination.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Antibodies, Monoclonal,
http://linkedlifedata.com/resource/pubmed/chemical/Antibodies, Monoclonal, Humanized,
http://linkedlifedata.com/resource/pubmed/chemical/ERBB2 protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/Receptor, erbB-2,
http://linkedlifedata.com/resource/pubmed/chemical/Vinblastine,
http://linkedlifedata.com/resource/pubmed/chemical/trastuzumab,
http://linkedlifedata.com/resource/pubmed/chemical/vinorelbine
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jun
|
|
pubmed:issn |
1526-8209
|
|
pubmed:author |
pubmed-author:Bayo-CaleroJuan LucasJL,
pubmed-author:CrespoCarmenC,
pubmed-author:Gómez-BernalAmaliaA,
pubmed-author:García-BuenoJosé MJM,
pubmed-author:García-PalomoAndrésA,
pubmed-author:González-FloresEncarnaciónE,
pubmed-author:IllaramendiJosé JJJ,
pubmed-author:MayordomoJosé IJI,
pubmed-author:Pérez-CarriónRamónR,
pubmed-author:Ramos-VázquezManuelM,
pubmed-author:Ruiz-BorregoManuelM,
pubmed-author:Sánchez-RoviraPedroP,
pubmed-author:Yubero-EstebanAlfonsoA,
pubmed-author:de la HabaJuanJ
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
8
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
264-8
|
|
pubmed:dateRevised |
2011-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:18650157-Adult,
pubmed-meshheading:18650157-Aged,
pubmed-meshheading:18650157-Antibodies, Monoclonal,
pubmed-meshheading:18650157-Antibodies, Monoclonal, Humanized,
pubmed-meshheading:18650157-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:18650157-Breast Neoplasms,
pubmed-meshheading:18650157-Female,
pubmed-meshheading:18650157-Humans,
pubmed-meshheading:18650157-Middle Aged,
pubmed-meshheading:18650157-Neoplasm Metastasis,
pubmed-meshheading:18650157-Patient Compliance,
pubmed-meshheading:18650157-Receptor, erbB-2,
pubmed-meshheading:18650157-Vinblastine
|
|
pubmed:year |
2008
|
|
pubmed:articleTitle |
A phase II study of weekly vinorelbine and trastuzumab in patients with HER2-positive metastatic breast cancer.
|
|
pubmed:affiliation |
Servicio de Oncología Médica, Hospital Juan Ramón Jiménez, Huelva, Spain. juanbayo@yahoo.es
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial, Phase II
|
